Associated Papers
[RAC2 gain-of-function mutations causing immunodeficiency drive activation of the NLRP3 inflammasome].
Doye A et al.
Medecine Sciences : M/s, 2025
RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation.
Doye A et al.
The Journal of Experimental Medicine, 2024
Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation.
Ashby L et al.
Clinical & Translational Immunology, 2024
Case Report: Profound newborn leukopenia related to a novel RAC2 variant.
Hall G et al.
Frontiers in Pediatrics, 2024
Not too little, not too much: the impact of mutation types in Wiskott-Aldrich syndrome and RAC2 patients.
Hsu AP
Clinical and Experimental Immunology, 2023
Novel Loss of Function (G15D) Mutation on RAC2 in a Family with Combined Immunodeficiency and Increased Levels of Immunoglobulin G, A, and E.
Duan X et al.
Journal of Clinical Immunology, 2023
A Novel RAC2 Mutation Causing Combined Immunodeficiency.
Zhang L et al.
Journal of Clinical Immunology, 2023
Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation.
Zhang L et al.
Journal of Clinical Immunology, 2022
A Novel RAC2 Variant Presenting as Severe Combined Immunodeficiency.
Stern H et al.
Journal of Clinical Immunology, 2021
Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.
Caye A et al.
Nature Genetics, 2015
Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping.
Arcila M et al.
The Journal of Molecular Diagnostics : Jmd, 2011
Select a paper to view details